N-methyl-4-methylpentanamine | 42763-51-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-methyl-4-methylpentanamine
• 英文别名: N-methyl-4-methylpentylamine；N-Isohexyl-N-methylamin；Methyl(4-methylpentyl)amine；N,4-dimethylpentan-1-amine
• CAS: 42763-51-9
• 化学式: C₇H₁₇N
• mdl: MFCD11212382
• 分子量: 115.219
• InChiKey: TUCUVZHDJRMHQX-UHFFFAOYSA-N

物化性质

• 沸点：
  128.1±8.0 °C(Predicted)
• 密度：
  0.751±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  8
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-methyl-4-methylpentanamine 在 双氧水 、 sodium cyanoborohydride 作用下， 以 甲醇 为溶剂， 反应 16.0h， 生成 (4E,8E,12E)-N-methyl-N-(4-methylpentyl)-16,17-epoxy-4,9,13,17-tetramethyl-4,8,12-octadecatrienylamine N-oxide
  参考文献：
  名称：

  Synthesis and biological activity of 19-azasqualene 2,3-epoxide as inhibitor of 2,3-oxidosqualene cyclase

  摘要：

  19-Azasqualene 2,3-epoxide and its N-oxide, high-energy intermediate analogue inhibitors of 2,3-oxidosqualene (SO) cyclase, were obtained by total synthesis. These compounds were designed to mimic the C-20 carbonium ion precursor of lanosterol formed during SO cyclization. The synthesis involved the preparation Of C22 squalenoid aldehyde epoxide through a new procedure and the reconstruction of the squalenoid chain bearing a nitrogen at C-19 (pro C-20). 19-Azasqualene 2,3-epoxide was active on SO cyclase from rat and pig liver with an IC50 of 1.5 muM in pig, while in SO cyclases of yeast (S cerevisiae and C albicans) microsomes it was 20-30-fold less active. It was inactive on squalene epoxidase from rat and pig liver at the highest concentrations tested (100 muM).

  DOI：

  10.1016/0223-5234(93)90026-b
• 作为产物：
  描述：

  N-methyl-4-methylpentanamide 在 lithium aluminium tetrahydride 作用下， 生成 N-methyl-4-methylpentanamine
  参考文献：
  名称：

  Long-range anisotropic effects of long chain amides

  摘要：

  DOI：

  10.1007/bf00899784

文献信息

• [EN] PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE PROTÉINE TYROSINE PHOSPHATASE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：CALICO LIFE SCIENCES LLC

  公开号：WO2020186199A1

  公开（公告）日：2020-09-17

  Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN 1 or PTPN2 inhibitor treatment, e.g., a cancer or a metabolic disease.

  本文提供了用于抑制蛋白酪氨酸磷酸酶的化合物、组合物和方法，例如蛋白酪氨酸磷酸酶非受体型2（PTPN2）和/或蛋白酪氨酸磷酸酶非受体型1（PTPN1），以及用于治疗对PTPN1或PTPN2抑制剂治疗有良好反应的相关疾病、紊乱和状况的方法，例如癌症或代谢性疾病。
• [EN] FARNESOID X RECEPTOR AGONISTS AND USES THEREOF<br/>[FR] AGONISTES DU RÉCEPTEUR X FARNÉSOÏDE ET LEURS UTILISATIONS
  申请人：METACRINE INC

  公开号：WO2017049177A1

  公开（公告）日：2017-03-23

  Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.

  本发明涉及法尼醇X受体激动剂化合物，制造此类化合物的方法，包含此类化合物的药物组合物和药品，以及使用此类化合物治疗与法尼醇X受体活性相关的状况、疾病或失调的方法。
• [EN] PRODRUGS OF KETAMINE, COMPOSITIONS AND USES THEREOF<br/>[FR] PROMÉDICAMENTS À BASE DE KÉTAMINE, COMPOSITIONS ET UTILISATIONS DE CEUX-CI
  申请人：XW LAB INC

  公开号：WO2019137381A1

  公开（公告）日：2019-07-18

  Provided are prodrugs of (S) -or (R) -ketamine, including isotopically labeled ketamine,composition and uses thereof. Compounds having formula (Ia) or (Ib) as the prodrugs of (S) -or (R) -ketamine, including isotopically labeled ketamine, and pharmaceutical compositions comprising the compounds provided herein are used for treating or preventing a CNS disease.More particularly, the related diseases include depression and pain. (Ia) (Ib)

  提供了（S）-或（R）-氯胺酮的前药，包括同位素标记的氯胺酮，其组成和用途。具有化学式（Ia）或（Ib）的化合物作为（S）-或（R）-氯胺酮的前药，包括同位素标记的氯胺酮，以及包含本文提供的化合物的药物组合物用于治疗或预防中枢神经系统疾病。更具体地，相关疾病包括抑郁症和疼痛。（Ia）（Ib）
• [EN] HERBICIDAL PYRIMIDINE COMPOUNDS<br/>[FR] COMPOSÉS HERBICIDES DE PYRIMIDINE
  申请人：BASF SE

  公开号：WO2018019574A1

  公开（公告）日：2018-02-01

  The present invention relates to the pyrimidine compounds of formula (I), or their agriculturally acceptable salts or derivatives as herbicides, wherein the variables are defined according to the description, use of pyrimidine compounds of formula (I) as herbicide, compositions comprising them and their use as herbicides, i.e. for controlling harmful plants, and also a method for controlling unwanted vegetation which comprises allowing a herbicidal effective amount of at least one pyrimidine compounds of the formula (I) to act on plants, their seed and/or their habitat.

  本发明涉及式(I)的嘧啶化合物，或其农业上可接受的盐或衍生物作为除草剂，其中变量根据描述定义，使用式(I)的嘧啶化合物作为除草剂，包含它们的组合物及其用作除草剂，即用于控制有害植物，以及一种控制不需要的植被的方法，该方法包括使至少一种式(I)的嘧啶化合物以除草有效量作用于植物、其种子和/或其栖息地。
• EFTU INHIBITORS OR AMINOTHIAZOLES AND THEIR USES
  申请人：LaMarche Matthew J.

  公开号：US20080221142A1

  公开（公告）日：2008-09-11

  The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases.

  本申请描述了对治疗、预防和/或改善疾病有用的有机化合物。